Former Director, CBER, U.S. Food and Drug Administration
Chief Executive and Scientific Officer, Sanaria Inc.
Chief Research and Development Officer, InDevR
Founder and CEO, Zola Therapeutics; Adjunct Professor, UMass Chan Medical School RNA Therapeutics Institute
Director, National Emerging Infectious Diseases Laboratories (NEIDL), Boston University
CEO and Chief Scientific Officer, Fina Biosolutions
Global Senior Unit Head Vaccine Drug Product Development, Global BioProcess Development, Sanofi
Professor, Disease Intervention and Prevention, Texas Biomedical Research Institute
Professor, Clinic of Infectious and Tropical Diseases, Department of Health Sciences, University of Milan, Italy
Professor, Center for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia; CEO, NXT Biologics
President and Co-founder, Center for Medicine in the Public Interest (CMPI)
Application Scientist, Integral Molecular
Chief Scientific Officer, Expres2ion Biotechnologies
Associate Professor of Medicine, Harvard Medical School; The Ragon Institute of Mass General, Harvard and MIT
Staff Scientist, Virology Laboratory, National Institute of Allergy and Infectious Diseases, NIH
CEO, Sentcell Ltd.; Professor, University College London, UK
Department of Microbiology, Cornell University
Principal Scientist, Infectious Disease and Vaccines Discovery, Merck Research Laboratories, Merck and Co., Inc.
Research Assistant Professor, Vanderbilt University Medical Center
Chief, Department of Virus-Host Interactions, Viral Diseases Branch, Walter Reed Army Institute of Research
Principal Scientist, Department of Biochemistry, Genetics and Microbiology, University of Pretoria, South Africa
Project Manager
Evaxion Biotech
Assistant Professor, Dept. of Biomedical Engineering, Dept. of Translational Medical Sciences, Texas A&M University
